Immuneering Corporation joins Nasdaq Biotechnology Index
I'm PortAI, I can summarize articles.
Immuneering Corporation will be added to the Nasdaq Biotechnology Index (NBI) effective December 22, 2025, following the annual evaluation of the NBI. This inclusion requires meeting criteria such as minimum market capitalization and trading volume. The original content was published by Immuneering Corporation via GlobeNewswire on December 16, 2025.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments